Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Advanced Proteome Therapeutics Corporation V.APC.H

Alternate Symbol(s):  APTCF

Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.


TSXV:APC.H - Post by User

Comment by Goldnboy1on Feb 10, 2021 6:35am
102 Views
Post# 32522178

RE:Will these guys miss the boat

RE:Will these guys miss the boat

This company has no interest in jumping into a fad vaccine. They totally considered it. But the fine print in the government rules did not suit them. 

So a decision was made to de prioritize this pursuit. 

Also at the time it was stated the company felt it was making necessary breakthroughs that would lead to monetization of their core technology. 

$APC.v is a conjugate cancer therapy combination drug. Essentially their therapy when added to pre existing drugs in their market. Reduces the toxicity by 15x. 

Similar tech to $TH.t. They just announced advanced trials related to a similar conjugate. 

In the end. This is about cancer patients undergoing chemo related treatment. Reducing toxicity. May mean less hair loss, less body aches, less nausea, less overall stress related to treatments. Etc. Just an overall enhancement of the drugs involved. 

Best part. Nine drugs own the entire market. 8/9 earn annual sales in excess of $1b. 

New trials with expanded cohorts coming. For a company that is broke and in desperate need of funding. Something has got to give. 

When they get a licence in the future, it will absolutely send this stock to the moon. Best part. Once one licence signs. Competitors will want to sign. 

We will be providing a bio best in class upgrade to their drugs. Can't see how that doesn't cause a bit of a frenzy. If this can all come to fruition. 

<< Previous
Bullboard Posts
Next >>